All eyes were on TAVR during the first round of late-breaking clinical trials at TCT 2023 in San Francisco. Researchers shared key updates related to devices from Edwards Lifesciences, Medtronic, Boston Scientific and JenaValve Technology.

Ziad Ali, MD, discusses the mixed results of the ILUMIEN IV trial comparing OCT vs angiography alone.

Akhil Narang, MD, explained that the two technologies can be used together to deliver high-quality patient care. 

The study included ECG data from more than 900,000 U.S. veterans.

According to Shockwave, the updated IVL catheter can deliver 50% more pulses than its previous offering. 

Radial access provides interventional cardiologists with a safe, effective alternative to femoral access during peripheral artery interventions.

Cybersecurity in the healthcare sector has been a growing concern, and medical imaging is one of the largest users of off-site cloud data storage.

Even as TAVR continues to build momentum as the go-to treatment option for many patients, researchers are keeping a close eye on the long-term safety and effectiveness of SAVR.